Eliana Perez Garcia
Pediatric Endocrinology · Mobile, ALNPI 1912383670
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,144 of the $4,646 with a category attached, or 89.2%. It is spread thinly across 30 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations.
Across 169 payments — averaging $27.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$744
- AbbVie$693
- Sanofi-aventis U.S. LLC$393
- Tolmar, Inc.$312
- Novo Nordisk$297
- BETA Bionics, Inc.$272
- plus $2K from 24 others
What the payments were for
- Travel & lodging$47110%
- Food & beverage$4,14489%
- Education$311%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 9 | $744 |
| AbbVie | 27 | $693 |
| Sanofi-aventis U.S. LLC | 12 | $393 |
| Tolmar, Inc. | 20 | $312 |
| Novo Nordisk | 14 | $297 |
| BETA Bionics, Inc. | 9 | $272 |
| Tandem Diabetes Care, Inc. | 8 | $202 |
| AstraZeneca | 3 | $177 |
| Xeris Pharmaceuticals, Inc. | 9 | $172 |
| Abbott | 4 | $148 |
| Ascendis Pharma Endocrinology Inc | 7 | $136 |
| Lilly USA, LLC | 5 | $113 |
| Pfizer | 6 | $107 |
| Azurity Pharmaceuticals, Inc. | 5 | $107 |
| Neurocrine Biosciences, Inc. | 4 | $103 |
| Dexcom, Inc. | 4 | $98 |
| Insulet Corporation | 2 | $80 |
| Alnylam Pharmaceuticals Inc. | 4 | $78 |
| Arbor Pharmaceuticals, Inc. | 3 | $58 |
| Rochester Medical Corporation | 1 | $56 |
| Kyowa Kirin, Inc. | 2 | $52 |
| Rhythm Pharmaceuticals, Inc. | 2 | $43 |
| Endo USA, Inc. | 2 | $43 |
| Travere Therapeutics, Inc. | 1 | $34 |
| Sequel Med Tech, LLC | 1 | $29 |
| Biomarin Pharmaceutical Inc. | 1 | $22 |
| Sanofi Pasteur Inc. | 1 | $22 |
| Eton Pharmaceuticals, Inc. | 1 | $21 |
| Tolmar Pharmaceuticals, Inc. | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InPen$441
- MINIMED 780G$147
- Lupron Depot$125
- TZIELD$120
How this compares
$4,646 in reported general payments places this provider in the 75th percentile of 22 pediatric endocrinology providers in Alabama.
Other pediatric endocrinology in Mobile
- Anne Marie KaulfersMobile$19K
- Whei Ying LimMobile$5K
- Kenneth RettigMobile$2K
- Samar BhowmickMobile$944
- Ambika AshrafBirmingham$39K
- Chelsea ZimmermanOpelika$29K
- Mary ScottBirmingham$9K
- Heather ChoatDothan$3K
- Kenneth McCormickBirmingham$2K
- Christy FosterBirmingham$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.